MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
GYRE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gyre Therapeutics (GYRE) Ownership - Who owns Gyre Therapeutics?

Gyre Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of small-molecule therapies for the treatment of organ fibrosis and inflammatory diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 858 567-7770
Employees
625
Web
https://www.gyretx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
594.78M
P/E Ratio
390.00
Total Cash
49.81M
Projected Growth
N/A
Total Debt
823K
Revenue
117.05M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.51
Total Debt/Equity
N/A
Revenue/Share
1.16 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
GYRE
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for GYRE
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
12770 High Bluff Drive
Phone
+1 858 567-7770
Employees
625
Web
https://www.gyretx.com